165 related articles for article (PubMed ID: 38297059)
1. Enhancing apoptosis-mediated anticancer activity of evodiamine through protein-based nanoparticles in breast cancer cells.
Solanki R; Rajput PK; Jodha B; Yadav UCS; Patel S
Sci Rep; 2024 Jan; 14(1):2595. PubMed ID: 38297059
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, and anticancer efficacy of evodiamine-loaded PLGA nanoparticles.
Zou L; Chen F; Bao J; Wang S; Wang L; Chen M; He C; Wang Y
Drug Deliv; 2016; 23(3):908-16. PubMed ID: 24904975
[TBL] [Abstract][Full Text] [Related]
3. Evodiamine from Evodia rutaecarpa induces apoptosis via activation of JNK and PERK in human ovarian cancer cells.
Chen TC; Chien CC; Wu MS; Chen YC
Phytomedicine; 2016 Jan; 23(1):68-78. PubMed ID: 26902409
[TBL] [Abstract][Full Text] [Related]
4. Folate Functionalized and Evodiamine-Loaded Pluronic Nanomicelles for Augmented Cervical Cancer Cell Killing.
Solanki R; Jangid AK; Jadav M; Kulhari H; Patel S
Macromol Biosci; 2023 Sep; 23(9):e2300077. PubMed ID: 37163974
[TBL] [Abstract][Full Text] [Related]
5. Evodiamine Prevents Glioma Growth, Induces Glioblastoma Cell Apoptosis and Cell Cycle Arrest through JNK Activation.
Wu WS; Chien CC; Liu KH; Chen YC; Chiu WT
Am J Chin Med; 2017; 45(4):879-899. PubMed ID: 28514905
[TBL] [Abstract][Full Text] [Related]
6. Evodiamine inhibits stemness and metastasis by altering the SOX9-β-catenin axis in non-small-cell lung cancer.
Panda M; Biswal BK
J Cell Biochem; 2022 Sep; 123(9):1454-1466. PubMed ID: 35788981
[TBL] [Abstract][Full Text] [Related]
7. Activation of JNK contributes to evodiamine-induced apoptosis and G2/M arrest in human colorectal carcinoma cells: a structure-activity study of evodiamine.
Chien CC; Wu MS; Shen SC; Ko CH; Chen CH; Yang LL; Chen YC
PLoS One; 2014; 9(6):e99729. PubMed ID: 24959718
[TBL] [Abstract][Full Text] [Related]
8. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
9. Evodiamine suppresses the progression of non-small cell lung carcinoma via endoplasmic reticulum stress-mediated apoptosis pathway
Li Y; Wang Y; Wang X; Jin L; Yang L; Zhu J; Wang H; Zheng F; Cui H; Li X; Jia Y
Int J Immunopathol Pharmacol; 2022; 36():3946320221086079. PubMed ID: 35388733
[TBL] [Abstract][Full Text] [Related]
10. BMP9 mediates the anticancer activity of evodiamine through HIF‑1α/p53 in human colon cancer cells.
Li FS; Huang J; Cui MZ; Zeng JR; Li PP; Li L; Deng Y; Hu Y; He BC; Shu DZ
Oncol Rep; 2020 Feb; 43(2):415-426. PubMed ID: 31894286
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effect of evodiamine in SGC-7901 human gastric adenocarcinoma cells via simultaneous induction of apoptosis and autophagy.
Rasul A; Yu B; Zhong L; Khan M; Yang H; Ma T
Oncol Rep; 2012 May; 27(5):1481-7. PubMed ID: 22367117
[TBL] [Abstract][Full Text] [Related]
12. Evodiamine and its nano-based approaches for enhanced cancer therapy: recent advances and challenges.
Solanki R; Patel S
J Sci Food Agric; 2024 May; ():. PubMed ID: 38821861
[TBL] [Abstract][Full Text] [Related]
13. Evodiamine, a plant alkaloid, induces calcium/JNK-mediated autophagy and calcium/mitochondria-mediated apoptosis in human glioblastoma cells.
Liu AJ; Wang SH; Chen KC; Kuei HP; Shih YL; Hou SY; Chiu WT; Hsiao SH; Shih CM
Chem Biol Interact; 2013 Sep; 205(1):20-8. PubMed ID: 23774672
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, physiochemical characterization, molecular docking study, and anti-breast cancer activity of silymarin loaded zein nanoparticles.
Jaiswal J; Rajput PK; Srivastav AK; Rao MJ; Yadav UCS; Kumar U
Int J Biol Macromol; 2024 Apr; 264(Pt 2):130679. PubMed ID: 38462110
[TBL] [Abstract][Full Text] [Related]
15. Development of EGFR-targeted evodiamine nanoparticles for the treatment of colorectal cancer.
Li C; Cai G; Song D; Gao R; Teng P; Zhou L; Ji Q; Sui H; Cai J; Li Q; Wang Y
Biomater Sci; 2019 Aug; 7(9):3627-3639. PubMed ID: 31328737
[TBL] [Abstract][Full Text] [Related]
16. Targeted nutlin-3a loaded nanoparticles inhibiting p53-MDM2 interaction: novel strategy for breast cancer therapy.
Das M; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2011 Apr; 6(3):489-507. PubMed ID: 21542687
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by evodiamine involves both activation of mitotic arrest and mitotic slippage.
Zhu LH; Bi W; Liu XD; Li JF; Wu YY; Du BY; Tan YH
Oncol Rep; 2011 Dec; 26(6):1447-55. PubMed ID: 21887472
[TBL] [Abstract][Full Text] [Related]
18. Evodiamine, a novel inhibitor of the Wnt pathway, inhibits the self-renewal of gastric cancer stem cells.
Wen Z; Feng S; Wei L; Wang Z; Hong D; Wang Q
Int J Mol Med; 2015 Dec; 36(6):1657-63. PubMed ID: 26497016
[TBL] [Abstract][Full Text] [Related]
19. Anticancer Potential of Silibinin Loaded Polymeric Nanoparticles against Breast Cancer Cells: Insight into the Apoptotic Genes Targets.
Pourgholi A; Dadashpour M; Mousapour A; Firouzi Amandi A; Zarghami N
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2587-2596. PubMed ID: 34452574
[TBL] [Abstract][Full Text] [Related]
20. Protein Kinase RNA-Like Endoplasmic Reticulum Kinase-Mediated Bcl-2 Protein Phosphorylation Contributes to Evodiamine-Induced Apoptosis of Human Renal Cell Carcinoma Cells.
Wu WS; Chien CC; Chen YC; Chiu WT
PLoS One; 2016; 11(8):e0160484. PubMed ID: 27483435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
